Baird Medical Investment (BDMD) vs NeuroOne Medical Technologies (NMTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
NeuroOne Medical Technologies (NMTC) has outperformed Baird Medical Investment (BDMD) over the past year, losing 82.9% versus a loss of 93.6%. NeuroOne Medical Technologies is the larger company by market cap ($5.9 million vs $5.1 million), about 1.2 times the size. NeuroOne Medical Technologies converts more of its revenue into profit, with a net margin of -39.6% versus -121.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDMD | NMTC |
|---|---|---|
| Share price | $0.0897 | $0.6521 |
| Market cap | $5.07M | $5.94M |
| 1-day change | -12.91% | -3.38% |
| YTD return | -93.40% | -85.66% |
| 1-year return | -93.64% | -82.91% |
| 5-year return | — | -95.19% |
| Forward P/E | 0.64 | — |
| EPS (TTM) | $-0.55 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $22.54M | $9.10M |
| Revenue growth (YoY) | -39.15% | +163.47% |
| Net income (latest FY) | $-27.28M | $-3.61M |
| Gross margin | 83.79% | 56.51% |
| Operating margin | -113.73% | -46.46% |
| Net margin | -121.04% | -39.63% |
| 52-week high | $3.70 | $6.12 |
| 52-week low | $0.073 | $0.61 |
| Distance from 52-week high | -97.58% | -89.34% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +4359.31% | +1014.86% |
| Average volume | 16.31M | 337.67K |
| Shares outstanding | 56.52M | 9.11M |
| Employees | 146 | 18 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NMTC has outperformed BDMD by 10.7 percentage points over the past year.
- NeuroOne Medical Technologies is more profitable, keeping -39.6 cents of every revenue dollar as net income versus -121.0 cents for Baird Medical Investment.
- NeuroOne Medical Technologies grew revenue faster in its latest fiscal year (+163.47% vs -39.15%).
About Baird Medical Investment
BDMD stock →Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.
Health Care · Medical/Dental Instruments · 146 employees
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Health Care · Medical/Dental Instruments · 18 employees
BDMD vs NMTC FAQ
Which is bigger, Baird Medical Investment or NeuroOne Medical Technologies?
NeuroOne Medical Technologies (NMTC) is larger, with a market capitalization of $5.94M compared with $5.07M for Baird Medical Investment (BDMD).
Which stock has performed better over the past year, BDMD or NMTC?
NMTC returned -82.91% over the past 12 months, compared with -93.64% for BDMD (price return, excluding dividends). Past performance does not predict future results.
Are Baird Medical Investment and NeuroOne Medical Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.